Pharmacokinetics and safety of twice-daily ritonavir-boosted atazanavir with rifampicin.
Gausi K, Mugerwa H, Siccardi M, Montanha MC, Lamorde M, Wiesner L, D'Avolio A, McIlleron H, Wilkins E, De Nicolò A, Maartens G, Khoo S, Kityo C, Denti P, Waitt C.
Gausi K, et al. Among authors: waitt c.
Clin Infect Dis. 2023 Nov 20:ciad700. doi: 10.1093/cid/ciad700. Online ahead of print.
Clin Infect Dis. 2023.
PMID: 37982585
Free article.